The store will not work correctly when cookies are disabled.
4-(5-((2-chloro-6-fluorophenyl)amino)-1H-pyrazolo[3,4-b]pyridin-1-yl)-N-methylthiophene-2-carboxamide
ID: ALA4857979
PubChem CID: 156155797
Max Phase: Preclinical
Molecular Formula: C18H13ClFN5OS
Molecular Weight: 401.85
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CNC(=O)c1cc(-n2ncc3cc(Nc4c(F)cccc4Cl)cnc32)cs1
Standard InChI: InChI=1S/C18H13ClFN5OS/c1-21-18(26)15-6-12(9-27-15)25-17-10(7-23-25)5-11(8-22-17)24-16-13(19)3-2-4-14(16)20/h2-9,24H,1H3,(H,21,26)
Standard InChI Key: JOWZBTCWJHFAQE-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
29.2236 -33.2591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9389 -32.8444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5082 -32.8444 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.2236 -34.0845 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.6954 -33.1835 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
31.2491 -32.5691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8343 -31.8537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0270 -32.0246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1683 -31.0993 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.3079 -29.7779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7544 -30.3882 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.0550 -30.1108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9706 -30.9345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6414 -31.4196 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.3970 -31.0780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4777 -30.2508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8060 -29.7735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2296 -29.9113 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.3095 -29.0899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0610 -28.7505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1412 -27.9298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4687 -27.4512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7183 -27.7947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6376 -28.6145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7319 -29.2342 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
28.5082 -32.0190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8905 -28.9556 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 1 0
1 4 2 0
2 5 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 2 2 0
7 9 1 0
9 13 1 0
12 10 1 0
10 11 2 0
11 9 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
16 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
20 25 1 0
3 26 1 0
24 27 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 401.85 | Molecular Weight (Monoisotopic): 401.0513 | AlogP: 4.38 | #Rotatable Bonds: 4 |
Polar Surface Area: 71.84 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 0.60 | CX LogP: 3.40 | CX LogD: 3.40 |
Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.53 | Np Likeness Score: -2.27 |
References
1. Feng Y, Park H, Ryu JC, Yoon SO.. (2021) N-Aromatic-Substituted Indazole Derivatives as Brain-Penetrant and Orally Bioavailable JNK3 Inhibitors., 12 (10.0): [PMID:34676036] [10.1021/acsmedchemlett.1c00334] |